test

Delmer Dee Raibourn III

@Avidity Partners Management Lp

Latest period2024 - Q3ReportedManaged Assets$1.96BTotal holdings81
Assets growth rate-16.7%Assets growth rate (2-Q avg)-20.41%Continuous growth in asset value0 quarters

Portfolio positions

This chart displays the top 10 holdings in Avidity Partners Management Lp's 2024 - Q3 portfolio, based on their 13F SEC filing, out of a total of 81 positions.

Assets under management

The assets under management (AUM) of Avidity Partners Management Lp over the past 10 years (40 quarters) show continuous growth in total asset value over the last 0 quarters. As of the latest 13F SEC filing for 2024 - Q3, they manage 1.96B in assets, with a quarterly growth rate of -16.7% and a 2-quarter average growth rate of -20.41%. The portfolio is managed by Delmer Dee Raibourn III, and others.

Portfolio holdings

CurrentNew PositionIncreasedDecreasedExited
InvestmentPortfolio %Reported Value
CGONCg Oncology Inc
Recent Activity
Increased 27.76%
3.19%
$62.481M
1.656M shares@ $37.73 avg price
CATXPerspective Therapeutics Inc
Recent Activity
Increased 13.38%
2.35%
$45.977M
3.444M shares@ $13.36 avg price
GKOSGlaukos Corp
Recent Activity
Increased 53.98%
2.3%
$44.934M
344,900 shares@ $130.28 avg price
IDYAIdeaya Biosciences Inc
Recent Activity
Increased 22.92%
2.22%
$43.497M
1.373M shares@ $31.68 avg price
INSMInsmed Inc
Recent Activity
Increased 37.68%
2.21%
$43.216M
592,000 shares@ $73.0 avg price
EXASExact Sciences Corp
Recent Activity
Increased 73.71%
2.05%
$40.055M
588,000 shares@ $68.12 avg price
RVMDRevolution Medicines Inc
Recent Activity
Increased 4.64%
1.83%
$35.827M
790,000 shares@ $45.35 avg price
PHATPhathom Pharmaceuticals Inc
Recent Activity
Increased 11.39%
1.67%
$32.625M
1.804M shares@ $18.08 avg price
XENEXenon Pharmaceuticals Inc
Recent Activity
Increased 8.49%
1.65%
$32.205M
818,000 shares@ $39.37 avg price
BHVNBiohaven Ltd
Recent Activity
Increased 3.34%
1.19%
$23.236M
465,000 shares@ $49.97 avg price